Adamas Announces Issuance of New U.S. Patent Covering GOCOVRI™
18. Dezember 2018 16:30 ET
|
Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., Dec. 18, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous...